Myeloma
Multiple myeloma/kahler’s disease is a cancer that forms in plasma cell. This disease can damage the bones, immune system, kidneys and red blood cell count. Symptoms are non-specific such as loss of appetite, bone pain, bone fractures, fatigue and fever. Treatments include chemotherapy, corticosteroids, radiation or a stem cell transplant.
Related Conference of Myeloma
Myeloma Conference Speakers
Recommended Sessions
- Anemia
- Biomarkers in Hematology and Oncology
- Blood Products
- Blood Tests
- Blood Transfusion
- Case reports and Epidemiology of Hematology & Hem-Oncology
- Erythroblastosis fetalis
- Haematology and Pharma Industry
- Hematologic Therapies
- Hematology Nursing
- Hemochromatosis
- Hemoglobinopathy
- HIV/AIDS
- Immunohematology
- Leukocytosis
- Lymphoma
- Myeloma
- Pediatric Hematology
- Stem Cell Therapy
- Thrombocytopenia
- Thrombosis
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (France)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (France)
- Biomarkers in Hematology and Oncology - Hematology Congress 2025 (Switzerland)
- Blood Disorders and the Immune System - Blood Disorders 2025 (France)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (France)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2025 (Switzerland)
- Cancer Genomics & Metabolomics - Hematology Congress 2025 (Switzerland)
- Case Reports in Hematology - Hematology Congress 2025 (Switzerland)
- Clinical Haematology - Hematology Congress 2025 (Switzerland)
- Cord Blood Transplantation - Hematology Congress 2025 (Switzerland)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (France)
- Digital Imaging in Hematology - Hematology Congress 2025 (Switzerland)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (France)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (France)
- Haematology and Pharma Industry - Hematology Congress 2025 (Switzerland)
- Hematologic Cancers - Hematology Congress 2025 (Switzerland)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (France)
- Hematology and Cardio-Oncology - Hematology Congress 2025 (Switzerland)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (France)
- Hematology Nursing - Hematology Congress 2025 (Switzerland)
- Hematology: Diagnostics and Screening - Hematology Congress 2025 (Switzerland)
- Hematopoietic Malignancies - Hematology Congress 2025 (Switzerland)
- Immunohematology - Hematology Congress 2025 (Switzerland)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (France)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (France)
- Neuro-Hematology - Hematology Congress 2025 (Switzerland)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (France)
- Organ Specific Cancer - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology - Hematology Congress 2025 (Switzerland)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (France)
- Stem Cell Therapy - Hematology Congress 2025 (Switzerland)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (France)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (France)
- Transfusion Medicines - Hematology Congress 2025 (Switzerland)
- Vascular Bleeding Disorders - Hematology Congress 2025 (Switzerland)